Literature DB >> 32283907

Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women

Betül Yavuz Keleş1, Meltem Vural2, Burcu Önder1, Kadriye Öneş1.   

Abstract

Background/aim: β1-selective beta-blockers (BBs) are sympatholytic agents, and discerning their effects on bone health would be of great importance. This study aimed to investigate the influence of β1-selective BBs on bone mineral density (BMD) and fracture risk. Materials and methods: This study included postmenopausal women who used β1-selective BBs (BB group) and control group. Sociodemographic characteristics, BMD and previous fragility fractures were recorded. Additionally, the 10-year probability of a major osteoporotic and hip fracture was calculated using the fracture risk assessment tool (FRAX).
Results: A total of 60 participants were included in the study. L1-4 and L2-4 BMD values were significantly higher in BB group than control group (P = 0.015 and P = 0.025, respectively). Moreover, T-scores of lumbar and femur total were significantly higher in the BB group. Two patients in BB and 6 patients in control group had previous fragility fracture. No statistically significant intergroup difference was noted regarding FRAX.
Conclusion: Based on our results, β1-selective BB usage was associated with higher BMD at the lumbar region in postmenopausal women. This work is licensed under a Creative Commons Attribution 4.0 International License.

Entities:  

Keywords:  bone mineral density; Adrenergic beta-antagonists; postmenopause

Year:  2020        PMID: 32283907      PMCID: PMC7379456          DOI: 10.3906/sag-1909-187

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  26 in total

1.  Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study.

Authors:  Shuman Yang; Nguyen D Nguyen; Jacqueline R Center; John A Eisman; Tuan V Nguyen
Journal:  Bone       Date:  2010-11-01       Impact factor: 4.398

Review 2.  Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots.

Authors:  Yuanyu Qiu; Wu Yang; Qijin Wang; Sijia Yan; Bo Li; Xiao Zhai
Journal:  Arch Osteoporos       Date:  2018-11-07       Impact factor: 2.617

3.  β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects.

Authors:  K A Toulis; K Hemming; S Stergianos; K Nirantharakumar; J P Bilezikian
Journal:  Osteoporos Int       Date:  2013-10-10       Impact factor: 4.507

4.  Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study.

Authors:  D A Hanley; J P Brown; A Tenenhouse; W P Olszynski; G Ioannidis; C Berger; J C Prior; L Pickard; T M Murray; T Anastassiades; S Kirkland; C Joyce; L Joseph; A Papaioannou; S A Jackson; S Poliquin; J D Adachi
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

Review 5.  The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.

Authors:  Joshua I Barzilay; Barry R Davis; Sara L Pressel; Alokananda Ghosh; Rachel Puttnam; Karen L Margolis; Paul K Whelton
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 6.  Drugs that may harm bone: Mitigating the risk.

Authors:  Faye N Hant; Marcy B Bolster
Journal:  Cleve Clin J Med       Date:  2016-04       Impact factor: 2.321

7.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

8.  Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells.

Authors:  A Togari; M Arai; S Mizutani; S Mizutani; Y Koshihara; T Nagatsu
Journal:  Neurosci Lett       Date:  1997-09-19       Impact factor: 3.046

9.  β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients.

Authors:  Hong Ji Song; Joongyub Lee; Ye-Jee Kim; Sun-Young Jung; Hwa Jung Kim; Nam-Kyong Choi; Byung-Joo Park
Journal:  Bone       Date:  2012-08-30       Impact factor: 4.398

10.  Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany.

Authors:  Marie-Therese Puth; Manuela Klaschik; Matthias Schmid; Klaus Weckbecker; Eva Münster
Journal:  BMC Musculoskelet Disord       Date:  2018-05-14       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.